Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05676008 · ClinicalTrials.gov registry record · NA
A Study of Positive Emotions With Long COVID-19
A NA study of Post-Acute COVID-19 Syndrome, sponsored by University of California, Davis.
- Active
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT05676008: Active NA study of Post-Acute COVID-19 Syndrome, sponsored by University of California, Davis.
NCT05676008 is a NA study of Post-Acute COVID-19 Syndrome that is active but no longer recruiting, run by University of California, Davis. The registered enrollment target is 400 participants, below the 815-participant average among 14 other Post-Acute COVID-19 Syndrome trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05676008, a NA study of Post-Acute COVID-19 Syndrome, is active but no longer recruiting, sponsored by University of California, Davis.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is testing a new brief mindfulness practice for people suffering from long COVID-19 symptoms. People suffering from long COVID are particularly vulnerable to negative emotions, as they must also cope with the long-term uncertainty of physical and psychological stress beyond the acute infection. The goal of the study is to measure the ability of a brief mindfulness practice to promote a sense of well-being in people suffering from long COVID.
Primary Outcome
14 items from the Mental Health Continuum Short Form
Conditions Studied
Interventions
- BEHAVIORAL Microdosing of mindfulness
Study Locations (1)
California
- University of California Davis - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2023-01-12 |
| Est. Completion | 2026-04 |
| Phase | NA |
What the registry record for NCT05676008 still lists
NCT05676008 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 815-participant average among 14 other Post-Acute COVID-19 Syndrome trials with a reported enrollment target (51% lower).
The record links to 1 condition, with Post-Acute COVID-19 Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Microdosing of mindfulness is the first listed.
NCT05676008 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05676008 about?
NCT05676008 is a clinical study titled "A Study of Positive Emotions With Long COVID-19". This study is testing a new brief mindfulness practice for people suffering from long COVID-19 symptoms. People suffering from long COVID are particularly vulnerable to negative emotions, as they must also cope with the long-term uncertainty of physical and psychological stress beyond the acute infe...
What is the current status of trial NCT05676008?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2023-01-12. Estimated completion is 2026-04.
What conditions does trial NCT05676008 study?
This clinical trial studies the following conditions: Post-Acute COVID-19 Syndrome.
What interventions are being tested in trial NCT05676008?
The interventions under investigation include: Microdosing of mindfulness (BEHAVIORAL).
Who is sponsoring clinical trial NCT05676008?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05676008 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post-Acute COVID-19 Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05676008's enrollment target sits among peer trials
400 2nd of 14 higher than 12 of 14 other Post-Acute COVID-19 Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Post-Acute COVID-19 Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Brain-Training Treatment for Long COVID in Older Adults
RECRUITING · NA
-
Long-Covid-19 Alleviation Through Learning Mindfulness Study
RECRUITING · NA
-
Long COVID Brain Fog: Cognitive Rehabilitation Trial
RECRUITING · NA
-
Care for Veterans Post-COVID-19
RECRUITING · NA
-
Dietary Intervention to Mitigate Post-Acute COVID-19 Syndrome
RECRUITING · NA
-
Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI